Indivior Pharmaceuticals, Inc. Common Stock
Veridion Score
Composite trend over time
Why is INDV moving today?
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for INDV.
INDV insider activity
Indivior Pharmaceuticals, Inc. Common Stock
6 insiders bought in the last 90 days
Net selling: -$38.7M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-23 | 2026-06-22 | Ciaffoni Joseph | Insider | sell | $38.32 | 612,549 | 790,330 | $23.5M | SEC Form 4 |
| 2026-06-12 | 2026-06-11 | Heidbreder Christian | Insider | sell | $38.06 | 18,586 | 227,923 | $707K | SEC Form 4 |
| 2026-06-10 | 2026-06-08 | Preblick Ryan | Insider | sell | $37.70 | 36,000 | 284,751 | $1.4M | SEC Form 4 |
| 2026-05-14 | 2026-05-12 | Thompson Juliet | Insider | sell | $38.28 | 1,117 | 6,455 | $43K | SEC Form 4 |
| 2026-03-17 | 2026-03-14 | Preblick Ryan | Insider | sell | $31.11 | 2,843 | 320,751 | $88K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 35 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moINDV contract awards, year to date.
Public federal awards linked to this ticker.
INDV lobbying filings, year to date.
Registered lobbying filings matched to Indivior Pharmaceuticals, Inc. Common Stock.